Qualigen Therapeutics Inc (QLGN) stock has fallen -64.13% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives QLGN stock a score of 4 out of a possible 100. That rank is chiefly influenced by a fundamental score of 0. QLGN stock has a mean target price of $9.00. This means analysts expect the stock to add 696.46% over the next 12 months. QLGN's rank also includes a long-term technical score of 4. The short-term technical score for QLGN is 10.
QLGN has an Overall Score of 4. Find out what this means to you and get the rest of the rankings on QLGN!